Study site

Edmonton, Alberta T6G2X8

1 studies enrolling now · 8 studies all time

What they study most

C1 Esterase Inhibitor Deficiency, C1 Esterase Inhibitor [C1-INH] Deficiency, C1 Esterase Inhibitor, Deficiency of, C1 Inhibitor Deficiency, Celiac Disease, Congenital Fibrinogen Deficiency, HAE With Normal C1 Esterase Inhibitor, Hereditary Angioedema, Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, Hereditary Angioedema - Type 3

Studies at this site

• Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema — Enrolling by invitation
• Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema — Completed
• Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema — Completed
• An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency — Completed
• Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease — Completed
• Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease — Completed
• Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease — Completed
• Prevention of Seasonal Affective Disorder — Completed